The MHRA awards Innovation Passports to those products it deems innovative, in order for them to be ...
Read moreThe Haute Autorité de Santé (HAS), recently announced changes to the conditions in which a drug wi...
Read moreOur Market Access analysts summarise the EUnetHTA draft scoping process and provide considerations a...
Read moreWe summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreAZ has warned its China revenues will decline mid-single-digit percentage in 2022 after years of dou...
Read moreThe HTA initially recommended Tremfya as a treatment option for adults with active psoriatic arthrit...
Read moreThe EUNetHTA recently published its draft scoping guidance which outlines how the contrasting decisi...
Read moreThey came up with six proposals, split into three subgroups, aimed at addressing the key barriers to...
Read moreNICE have been clear that this framework should not be interpreted as minimum standards for real-wor...
Read moreIt is widely expected that the reform will entail the unification of the CTS and the CPR into one bo...
Read more